{
  "case_id": "case_0010",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 48.89,
    "sex": "Male",
    "genderIdentity": "Cisgender Male",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\n  \nMore precision is possible than: 'right optic nerve'.  \nNamely, lesions in the region of: bilateral optic nerve and right T2 spinal cord.\n  \nThe suggested lesion left parasagittal frontoparietal cortex (leg area) not necessary to explain the signs.",
      "structured_data": {
        "gt_lesions_english": [
          "right T2 myelopathy",
          "bilateral optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "parasagittal frontoparietal cortex (leg area)",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [],
        "imprecise_matches": [
          [
            "right optic nerve",
            [
              "bilateral optic nerve (cranial nerve II)",
              "right T2 myelopathy"
            ]
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": [
          "left parasagittal frontoparietal cortex (leg area)"
        ]
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 0,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 0,
        "additional_lesion_count": 1,
        "proportion_correct": 0.0,
        "proportion_imprecise": 0.5,
        "proportion_missed": 0.0,
        "proportion_additional": 0.5
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+) and MOGAD.\n\nOther possible differentials:\n- Neurosarcoid, SLE and Neurosyphilis.\n- Also feasible but low probability: Lyme, Beh\u00e7et's and ADEM.\n\nLess plausible as unifying explanation for the full clinical presentation:\n- Left parasagittal meningioma or other space-occupying lesion compressing the medial frontal and parietal lobes (atypical for bilateral optic nerve and unilateral spinal cord involvement)\n- Anterior cerebral artery territory infarct affecting parasagittal frontoparietal cortex (atypical for bilateral optic nerve and unilateral spinal cord involvement)\n- Optic Neuropathy (atypical for bilateral optic nerve and unilateral spinal cord involvement)\n- NAION (atypical for bilateral optic nerve and unilateral spinal cord involvement)\n- Subacute combined degeneration of the cord due to vitamin B12 deficiency (plausible for bilateral optic nerve, but atypical for unilateral spinal cord involvement)\n- Diabetic length-dependent peripheral polyneuropathy",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder",
          "MOG antibody\u2013associated disease",
          "Left parasagittal meningioma or other space-occupying lesion compressing the medial frontal and parietal lobes",
          "Anterior cerebral artery territory infarct affecting parasagittal frontoparietal cortex",
          "Non-arteritic anterior ischaemic optic neuropathy of the right eye",
          "Subacute combined degeneration of the cord due to vitamin B12 deficiency",
          "Diabetic length-dependent peripheral polyneuropathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "AQP4_NMOSD",
          "MS",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "Neurosarcoidosis",
          "Behcet_Disease",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "Syphilis"
        ],
        "missing_common_names": [
          "Neurosarcoid",
          "SLE",
          "Neurosyphilis"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "Beh\u00e7et's",
          "ADEM"
        ],
        "additional_diagnoses": [
          "Left parasagittal meningioma or other space-occupying lesion compressing the medial frontal and parietal lobes",
          "Anterior cerebral artery territory infarct affecting parasagittal frontoparietal cortex",
          "Non-arteritic anterior ischaemic optic neuropathy of the right eye",
          "Subacute combined degeneration of the cord due to vitamin B12 deficiency",
          "Diabetic length-dependent peripheral polyneuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 5,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 9,
        "lesion_ddx_matched_count": 3,
        "lesion_ddx_missed_common_count": 3,
        "lesion_ddx_missed_low_prob_count": 3,
        "lesion_ddx_coverage_percentage": 0.3333333333333333
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain; Cervical Spine; Thoracic Spine, and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: ESR, ANA, CRP, anti-MOG, syphilis, ENA, ACE, lyme, anti-AQP4.\n- Could also consider testing: anti-dsDNA.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and whole spine with gadolinium contrast including dedicated orbital sequences",
          "Ophthalmology slit-lamp and dilated fundus examination",
          "Optical coherence tomography of both optic nerves and maculae",
          "Automated visual field testing (perimetry)",
          "Visual evoked potentials",
          "Lumbar puncture for opening pressure measurement",
          "CSF cell count and differential",
          "CSF protein and glucose",
          "CSF oligoclonal bands and IgG index",
          "Serum aquaporin-4 IgG antibodies",
          "Serum MOG IgG antibodies",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "HbA1c",
          "Serum vitamin B12 level",
          "Serum folate level",
          "Serum methylmalonic acid level",
          "Thyroid-stimulating hormone",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "ANCA",
          "Serum ACE level",
          "Serum copper and ceruloplasmin",
          "Screening for HIV, syphilis and Lyme disease as locally appropriate",
          "Nerve conduction studies and electromyography",
          "ECG"
        ],
        "all_identified_ft_keys": [
          "ANA",
          "ANCA",
          "LFT",
          "NCS_EMG",
          "Vitamin_B12",
          "MRI_Whole_Spine",
          "MOG_Antibodies",
          "VEP",
          "MRI_Lumbosacral_Spine",
          "FBC",
          "CSF_General",
          "ENA_Panel",
          "Serum_ACE",
          "Serum_Ceruloplasmin",
          "Lyme_Serology",
          "Serum_Copper",
          "MRI_Cervical_Spine",
          "U_and_E",
          "MRI_Brain",
          "Automated_Visual_Fields",
          "ESR",
          "TFT",
          "Serum_Immunoglobulins",
          "ECG",
          "OCT",
          "CSF_Opening_Pressure",
          "CSF_Oligoclonal_Bands",
          "Folate",
          "Methylmalonic_Acid",
          "Ophthalmology Assessment",
          "HIV_Test",
          "CRP",
          "MRI_Thoracic_Spine",
          "Syphilis_Serology",
          "Glucose_HbA1c",
          "AQP4_Antibodies",
          "MRI_Orbits"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "ESR",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Syphilis_Serology",
          "Serum_ACE",
          "ENA_Panel",
          "Lyme_Serology",
          "Anti_dsDNA",
          "AQP4_Antibodies"
        ],
        "found_inv_keys_ddx": [
          "ESR",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Syphilis_Serology",
          "ENA_Panel",
          "Serum_ACE",
          "Lyme_Serology",
          "AQP4_Antibodies"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 5,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 10,
        "ddx_tests_found_count": 9,
        "ddx_tests_coverage_percentage": 0.9
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Steroids would require caution due to comorbidity Type 2 diabetes mellitus.\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g daily for 3\u20135 days) followed by an oral steroid taper",
            "timing": "Start Now",
            "reasons": [
              "Subacute monocular visual loss with right RAPD consistent with inflammatory optic neuritis",
              "Objective evidence of a concurrent central sensorimotor lesion suggesting active inflammatory demyelination",
              "Early corticosteroid therapy hastens recovery in optic neuritis and myelitis and may limit permanent deficit",
              "To be initiated immediately after MRI excludes compressive, haemorrhagic or infectious lesions"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and gastric protection while receiving high-dose corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "High-dose systemic steroids increase risk of gastrointestinal bleeding and dyspepsia",
              "Prophylaxis reduces steroid-related gastric complications"
            ]
          },
          {
            "treatment": "Venous thromboembolism prophylaxis with low-molecular-weight heparin and mechanical measures as appropriate",
            "timing": "Start Now",
            "reasons": [
              "Right leg weakness and gait unsteadiness reduce mobility, increasing VTE risk",
              "High-dose steroids may further increase thrombotic risk"
            ]
          },
          {
            "treatment": "Physiotherapy and gait/balance rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Right lower limb spastic weakness and sensory ataxia predispose to falls",
              "Early rehabilitation improves functional outcome and mobility",
              "Helps manage spasticity and optimises walking pattern"
            ]
          },
          {
            "treatment": "Optimisation of diabetes control and vascular risk factor management",
            "timing": "Start Now",
            "reasons": [
              "Type 2 diabetes increases risk of additional microvascular optic and CNS events",
              "Good glycaemic and blood pressure control supports neurological recovery and reduces future risk"
            ]
          },
          {
            "treatment": "Plasma exchange for steroid-refractory optic neuritis or myelitis",
            "timing": "Delay",
            "reasons": [
              "Reserved for cases with poor response to first-line high-dose steroids",
              "Particularly important if NMOSD or MOGAD is confirmed or strongly suspected",
              "Requires availability of specialised resources and confirmation of diagnosis"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for an inflammatory demyelinating disease (e.g., multiple sclerosis or NMOSD-specific immunotherapy)",
            "timing": "Delay",
            "reasons": [
              "Choice of agent depends on definitive diagnosis from MRI, CSF and serology",
              "Needs detailed risk\u2013benefit discussion and baseline safety screening",
              "Not appropriate to start before establishing whether this is MS, NMOSD, MOGAD or another condition"
            ]
          },
          {
            "treatment": "Vitamin B12 replacement if deficiency is identified",
            "timing": "Delay",
            "reasons": [
              "B12 deficiency can mimic or contribute to myelopathy and sensory ataxia",
              "Replacement is only indicated if laboratory testing confirms deficiency"
            ]
          },
          {
            "treatment": "Regular ophthalmology follow-up and visual rehabilitation where needed",
            "timing": "Delay",
            "reasons": [
              "Visual outcome and need for further intervention can only be assessed after acute treatment",
              "Vision aids and rehabilitation are tailored to residual deficits"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone (e.g., 1 g daily for 3\u20135 days) followed by an oral steroid taper",
            "timing": "Start Now",
            "reasons": [
              "Subacute monocular visual loss with right RAPD consistent with inflammatory optic neuritis",
              "Objective evidence of a concurrent central sensorimotor lesion suggesting active inflammatory demyelination",
              "Early corticosteroid therapy hastens recovery in optic neuritis and myelitis and may limit permanent deficit",
              "To be initiated immediately after MRI excludes compressive, haemorrhagic or infectious lesions"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse."
              ],
              "contraindications": [
                "Steroids potentially inappropriate due to comorbidity Type 2 diabetes mellitus."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Steroids would require caution due to comorbidity Type 2 diabetes mellitus.\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for an inflammatory demyelinating disease (e.g., multiple sclerosis or NMOSD-specific immunotherapy)",
            "timing": "Delay",
            "reasons": [
              "Choice of agent depends on definitive diagnosis from MRI, CSF and serology",
              "Needs detailed risk\u2013benefit discussion and baseline safety screening",
              "Not appropriate to start before establishing whether this is MS, NMOSD, MOGAD or another condition"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 1,
          "reasons_acknowledged": 1,
          "reasons_missed": 0,
          "reasons_coverage_percentage": 1.0
        }
      }
    }
  }
}